ASCAD 3rd Congress

Register

Deadline 31.01.2024

Preparation of your abstract
Abstracts must be submitted in English. A “blind” selection process will be used.
No identifying features such as names of hospitals, medical schools, clinics or cities may be listed in the title or text of the abstract. Do not include the names of authors either. Their names and affiliations (institutions) will be registered separately when submitting the abstract online. The title should not be written entirely in capital letters.
The size of the abstract is limited to 3,000 characters.
The submission program will automatically calculate the size of your abstract and will not allow submissions that do not fit in the size requirements.
Tables and figures (graphs) are allowed and they are not taken into consideration for the character count. On the other hand, pictures of patients and body parts are NOT allowed. Abstract containing pictures will be rejected.
In order to be able to submit your abstract you must use the template downloadable on the submission platform.
Check spelling and grammar carefully. Direct reproduction from your electronically submitted abstract text means that any errors in spelling, grammar or scientific data will be reproduced as submitted.
Use generic names. The use of commercial drug names, brands and registered trademarks are strictly prohibited.
Drugs should be referred to by the active substance or pharmacological designation. No mention of pharmaceutical company names should be included in the abstract.
The authors should specify if they prefer their submission to be considered for:

e-Poster presentation only
Oral presentation only